Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9KD9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,751
Award facts
- Contract value 100% obligated
- $27,750.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27.75K to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on January 7, 2026, with completion scheduled for January 8, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. That underlying IDC, valued at up to $999.99M through December 2031, serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the breadth of specialty medications supplied through this contract vehicle.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's substantial contract portfolio with DLA demonstrates its capability to fulfill diverse medical supply needs across multiple therapeutic domains, from specialty medications to vaccines and medical devices. The delivery order structure and firm fixed-price arrangement are consistent with AmerisourceBergen's typical federal contracting approach, which historically involves competitive awards for specific pharmaceutical products ranging from nominal amounts to orders exceeding $45K. This particular award exemplifies the company's role in ensuring consistent pharmaceutical supply availability for Defense Health Agency beneficiaries and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9KD9?
SPE2DR26F9KD9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9KD9 worth?
The government has obligated $27,751 on SPE2DR26F9KD9.
Is contract SPE2DR26F9KD9 an order under another contract?
Yes. SPE2DR26F9KD9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KD9 competed?
The extent of competition for SPE2DR26F9KD9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award